loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering 7544713

    Client Virtual Booth
    Menu

    United Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 UNITED THERAP (5)

    filter

    01 7544713 (5)

    filter

    01 Blank (5)

    filter

    01 Blank (5)

    filter

    01 2024-07-14 (5)

    refreshReset Filter
    refreshReset Filter
    price-trendAsk Us

    UNITED THERAP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TREPROSTINIL DIOLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7544713
    2024-07-14
    U-1475
    203496
    USE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
    3
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    UNITED THERAP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TREPROSTINIL DIOLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7544713
    2024-07-14
    U-1475
    203496
    USE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    UNITED THERAP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TREPROSTINIL DIOLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7544713
    2024-07-14
    U-1475
    203496
    USE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    UNITED THERAP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TREPROSTINIL DIOLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7544713
    2024-07-14
    U-1475
    203496
    USE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
    4
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    UNITED THERAP

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    TREPROSTINIL DIOLAMINE

    PDF Supplier PDF
    URL Supplier Web Content
    7544713
    2024-07-14
    U-1475
    203496
    USE OF ORENITRAM FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1).
    5
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY